Targeted LNPs deliver mRNA encoding IL-15 superagonists to balance efficacy and toxicity in cancer therapy - Yu, Juntao; Li, Qian; Luo, Shenggen; Wang, Xiaona; Cheng, Qiang; Hu, Rongkuan (bioRxiv, 2024)
Keywords: Adaptive immunity; Antitumor agents; Bioengineering; Cancer therapies; Intellectual property; Interleukin 15; Metastases; mRNA; Nanoparticles; Toxicity; Tumors